期刊文献+

慢性阻塞性肺疾病患者血清白细胞介素-6、白细胞介素-8与肺功能水平的相关性分析 被引量:2

The correlation between the serum interleukin-6,interleukin-8 and pulmonary function level of chronic obstructive pulmonary disease patients
下载PDF
导出
摘要 目的探讨细胞因子IL-6与IL-8在慢性阻塞性肺疾病(COPD)发病中的作用。方法采用放射免疫法分别检测60例COPD急性加重期患者(实验组)在常规治疗前后及60例健康成人(健康对照组)血清白细胞介素-6、白细胞介素-8及FEV1/FVC等指标。结果实验组血清IL-6、IL-8及FEV1/FVC在治疗前后差异均有统计学意义(P<0.05)。治疗后实验组与健康对照组比较IL-6无统计学意义(P>0.05),IL-8及FEV1/FVC有统计学意义(P<0.05)。结论 IL-6参与了急性期COPD气道炎症反应,IL-8参与了COPD的发生与发展全过程,IL-6、IL-8水平与肺功能之间存在相关性。 Objective To investigate the cytokine IL-6 and IL-8 in the pathogenesis of chronic obstructive pulmonary disease. Methods Examined separately serum interleukin-6, interleukin-8 and FEV1/FVC of the 60 cases with acute ex- acerbation of COPD in the conventional before and after therapy, and 60 healthy adult by radioimmunoassay. Results In the experimental group, significant difference in levels of serum IL-6, 1L-8 and FEV1/FVC before and after therapy (P 〈 0.05). After treatment compared with the healthy control group, no significant difference in IL-6, but there were significant differ- ences in the IL-8 and FEV1/FVC. Conclusion IL-6 involved in the acute phase of COPD airway inflammation,lL-8 in- volved entirely in the occurrence of COPD and the development,IL-6 and IL-8 levels are relevant to lung function.
出处 《中国现代医生》 2012年第31期36-37,共2页 China Modern Doctor
基金 江西省南昌市2011年科技支撑计划项目(项目申报代码:洪科发广十[2011]字87号 项目编号:16号)
关键词 IL-6 IL-8 慢性阻塞性肺疾病 肺功能 Interleukin-6 Interleukin-8 Chronic obstructive pulmonary disease Lung function
  • 相关文献

参考文献11

  • 1Global Initiative for Chronic Obstructive Lung Disease (G0LD)[S]. 2007 ,Accessed March 28.
  • 2Barnes PJ, Shapiro SD ,Pauwels RA. Chronic obstructive pulmonarydisease:mole-cular and cellular mechanisms[J]. Eur Respir J,2003,22(4):672-688.
  • 3Jeffery P K. Remodedjng and inflammation of bronchi in asthma andchronic obstructive pulmonary disease[J]. Proceedings of the ATS, 2004,1(3):176-183.
  • 4Hill AT,Bayley D, Stoeldey RA. The interrelationship of sputum inflam-motary makers in patients with chronic bronchitis[J]. Am J Rspir CritCare Med,1999,160(3):893-898.
  • 5Keatings VM,Cave SJ,Henry MJ,et al. A polymorphism in the tumo-meerosis factor-alpha gene promoter region may predispose to a poor-prognosis in COPD[J]. Chest ,2000,118(4) :971-975.
  • 6吴荣华,许健辉,黄平,陈嘉馨,李永强,梁栋伟,梁伟权.COPD患者血清IL-8、hs-CRP水平变化的临床研究[J].中国当代医药,2011,18(19):28-30. 被引量:11
  • 7冯志军,滕伟.痰热清注射液对COPD急性加重期患者血清C反应蛋白(CRP)、IL-8和IL-17表达的影响[J].中外医疗,2010,29(19):83-84. 被引量:10
  • 8De Boer WI. Cytokines and therapy in COPD: a promising combination[J].Chest ,2002, 121 (5):209-218.
  • 9何智辉,陈平.慢性阻塞性肺疾病患者体内白介素-6和C反应蛋白质量浓度的变化及意义[J].中国实用内科杂志,2006,26(7):989-991. 被引量:50
  • 10Pionto-Plate VM ,Livnat G, Cabral H ,et al. Systemic cytokines, clini-cal and physiological changes in patients hospitalized for exacerbationof C0PD[J]. Chest, 2007,131(1): 37-43.

二级参考文献19

共引文献68

同被引文献70

引证文献2

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部